Floatz logo

METHOTREXATE

Hematopoietic Stem Cell Transplantation

The First Affiliated Hospital of Soochow UniversitySmall moleculePhase 3Active
BB
70/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
57/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Hematopoietic Stem Cell Transplantation cohort.

Asset / SponsorPhaseRating
TACROLIMUS
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 3BB
CYCLOSPORIN A
The First Affiliated Hospital of Soochow University
Phase 4BB
Folic Acid
Peking University
Phase 4BB
Erythropoietin Human Recombinant
Peking University
Phase 4BB
IRON SUCCINATE (FE(O4C4H4))
Peking University
Phase 4BB

View all 15 →

Same molecule, other indications

METHOTREXATE is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →
acute promyelocytic leukemiaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →